Pharma giant Johnson & Johnson reported its second-quarter earnings, beating the analysts’ estimates on profit and revenue. Additionally, the company lowered its full-year profit forecast to account for the costs of mergers and acquisitions.
Johnson & Johnson had $2.82 in earnings per share in Q2...
Pharma giant Johnson & Johnson is expecting to have a better 2023 performance after reporting strong second-quarter earnings on Wednesday. The company benefited from a well-performing medical devices business that saw significant sales growth in the first part of the year. It also benefited...
